Pantup (Pantoprazole)

Pantoprazole selectively blocks the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This inhibition stops the final step of acid secretion, leading to a marked decrease in gastric acidity and allowing damaged tissue in the stomach and esophagus to heal.

The prescribed dose of Pantup is determined by a qualified healthcare professional based on the patient’s specific condition, severity and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions and local prescribing guidelines.

Pantoprazole is classified as pregnancy category B in many regions, indicating no evidence of risk in animal studies but limited human data. It should only be used during pregnancy or lactation if the potential benefit justifies the potential risk, and the decision must be made by the treating physician.

To request Pantup, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantup (pantoprazole) is similar in efficacy to other PPIs such as omeprazole or esomeprazole for acid‑related disorders, but it has a lower potential for drug‑drug interactions mediated by CYP2C19 metabolism. Its once‑daily dosing and favorable safety profile make it a common choice for long‑term acid suppression.

Pantup tablets should be stored at temperatures below 25 °C, in the original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s potency and stability throughout its shelf life.

Pantup is taken orally, usually as a whole tablet with water. It can be taken with or without food, but consistent timing each day helps maintain steady acid control. Patients should follow the prescribing clinician’s instructions regarding timing and duration of therapy.

Serious, though rare, risks include Clostridioides difficile‑associated colitis, acute interstitial nephritis, severe allergic reactions such as anaphylaxis, and hypomagnesemia which can lead to muscle cramps or cardiac arrhythmias. Any signs of these conditions require immediate medical attention.

Pantup is contraindicated in individuals with known hypersensitivity to pantoprazole or any other component of the formulation. Caution is also advised for patients with severe liver impairment, and it should be used only under medical supervision in those with a history of allergic reactions to other proton pump inhibitors.